Latest Supply Chain Disruptions News

Metallium Limited is set to commission its first Flash Joule Heating processing line in Texas by December 2025, expanding capacity fivefold and adding a second rare earth demonstration line. This move positions the company as a key player in non-Chinese critical metals refining amid tightening Chinese export controls.

IperionX has received an additional $25 million from the U.S. Department of War to accelerate titanium production at its Virginia facility, reinforcing domestic supply chains for critical defense materials.

Yancoal Australia Ltd reported a sharp 61% drop in net profit for the first half of 2025 amid falling coal prices and supply chain disruptions, despite a 15% rise in production. The company declared a fully franked interim dividend and is advancing strategic acquisitions and sustainability initiatives.

Premier Investments reported a 31.1% rise in net profit after tax for FY25, driven by strong growth in its continuing operations after divesting its Apparel Brands to Myer. The company is now concentrating on expanding its high-margin Peter Alexander and Smiggle brands.

AIMS Property Securities Fund (APW) reported a remarkable financial year ending June 2025, with net income and revenue more than doubling and net tangible assets per unit rising 31.8%. The fund’s conservative, debt-free approach and diversified portfolio helped it outperform the broader market despite ongoing distribution suspensions.

Dusk Group Limited reported solid financial growth for FY25, with revenue up 7.8% and net profit rising 5.5%, underpinned by strong online sales and strategic store expansions.

Clinuvel Pharmaceuticals has reported a robust financial year ending June 2025, marked by solid revenue growth and sustained profitability, while advancing its clinical pipeline and maintaining a strong balance sheet.

Eagers Automotive Limited has announced a fully franked interim dividend of AUD 0.24 per share for the half-year ending June 2025, signaling steady returns for shareholders.

Nova Eye Medical Limited reported a 25% increase in revenue to AUD 29.3 million for FY2025, driven by strong sales in its glaucoma surgical devices segment, yet posted a net loss after tax of AUD 9.1 million. The company raised AUD 6.2 million through a share placement to support growth initiatives.

Optiscan Imaging Limited has launched a $17.75 million fully underwritten entitlement offer to fund clinical trials, regulatory approvals, and product development. Peters Investments underwrites the offer, potentially increasing its stake to nearly 39%.

Woolworths Group reported a 3.6% normalised sales increase to $69.1 billion for FY25, yet earnings before interest and tax fell 12.6%, weighed down by Australian Food and BIG W segments. The group plans a turnaround in FY26 amid ongoing cost pressures and strategic shifts.

Woolworths Group posted a modest 1.7% revenue increase to $69.1 billion for the 52 weeks ending June 2025, while earnings before interest and tax (EBIT) fell 12.6%, weighed down by challenges in its Australian Food and BIG W segments.